"Memorial Sloan Kettering Cancer Center
1275 York Ave.
Unfledged York, NY 10021
Common States"

Looks like they used some kind of translation program, maybe?

Kathleen

2009/7/22 Nic Marais <[log in to unmask]>

> OMG!
>
> "The late study shows that therapeutic cloning can take up Parkinson's
> disease in a mouse follow."
>
> "While this current business is in animals, it could have future
> implications as this method may be an effective habit to reduce transplant
> rejection and heighten recapture in other diseases and in other organ
> systems."
>
> (To quote only some of numerous examples;-)
>
> But who cares about the Japenglish of their reports. As long as they carry
> on with the good work!
>
> Nic 57/15
>
>
> On Wed, Jul 22, 2009 at 7:12 AM, rayilynlee <[log in to unmask]> wrote:
>
> > Therapeutic Cloning Treats Parkinson's Disease In Mice
> > July 20, 2009
> > Research led by investigators at Statue Sloan-Kettering Cancer Center
> > (MSKCC) has shown that salutary cloning, also known as somatic-cell
> nuclear
> > transfer (SCNT), can be used to expound on Parkinson's disease in mice.
> The
> > study's results are published in the Procession 23 online number of the
> > minutes Nature Drug.
> >
> > For the principal term, researchers showed that health-giving cloning or
> > SCNT has been successfully used to study disease in the selfsame subjects
> > from whom the endorse cells were derived. While this current business is
> in
> > animals, it could have future implications as this method may be an
> > effective habit to reduce transplant rejection and heighten recapture in
> > other diseases and in other organ systems.
> >
> > In therapeutic cloning or SCNT, the focus of a somatic cell from a donor
> > subject is inserted into an egg from which the heart has been removed.
> This
> > cell then develops into a blastocyst from which embryonic stem cells can
> be
> > harvested and differentiated for corrective purposes. As the genetic dirt
> in
> > the resulting staunch cells comes from the donor subject, healthy cloning
> or
> > SCNT would yield obedient to-unique to cells that are spared by the
> > invulnerable system after transplantation.
> >
> > The late study shows that therapeutic cloning can take up Parkinson's
> > disease in a mouse follow. The scientists used skin cells from the tail
> of
> > the creature to fashion customized or autologous dopamine neurons the
> > missing neurons in Parkinson's disease. The mice that received neurons
> > derived from one at a time matched stem cell lines exhibited neurological
> > recovery. But when these neurons were grafted into mice that did not
> > genetically match the transplanted cells, the cells did not survive well
> and
> > the mice did not recover.
> >
> > The work was led by higher- ranking author Lorenz Studer, MD, Head of the
> > Shoot Stall and Tumor Biology Laboratory within the Sloan-Kettering Begin
> at
> > MSKCC, and get up to author Viviane Tabar, MD, Neurosurgeon and control
> room
> > scientist at MSKCC. The work was performed in collaboration with
> scientists
> > at the Riken Alliance in Kobe, Japan.
> >
> > Other MSKCC researchers who contributed to this study are: Mark
> Tomishima,
> > Georgia Panagiotakos, George Al-Shamy, Bill Chan, and Jayanthi Menon.
> > Scientists in Japan include group leader Teruhiko Wakayama and scientists
> > Eiji Mizutani, Sayaka Wakayama and Hiroshi Ohta. This research was
> supported
> > by the US National Institute of Neurological Disorders and Strike, the
> Starr
> > Tri-institutional Stem Chamber Initiative, the Michael J. Fox Foundation
> > seeking Parkinson's Research, the Michael W. McCarthy Fundamental
> principle
> > and an unrestricted grant from the Kinetics Understructure.
> >
> > Memorial Sloan Kettering Cancer Center
> > 1275 York Ave.
> > Unfledged York, NY 10021
> > Common States
> > http://www.mskcc.org
> >
> > Rayilyn Brown
> > Director AZNPF
> > Arizona Chapter National Parkinson Foundation
> > [log in to unmask]
> > ----------------------------------------------------------------------
> > To sign-off Parkinsn send a message to: mailto:
> > [log in to unmask]
> > In the body of the message put: signoff parkinsn
> >
>
> ----------------------------------------------------------------------
> To sign-off Parkinsn send a message to: mailto:
> [log in to unmask]
> In the body of the message put: signoff parkinsn
>

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn